Development and pilot testing of a PrEP communication intervention and integration into existing HIV testing services for female IV drug using clients of a needle exchange

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2018
    2021
  • Known Financial Commitments (USD)

    $158,500
  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

    Pending
  • Research Location

    United States of America, Americas
  • Lead Research Institution

    TEMPLE UNIV OF THE COMMONWEALTH
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Approaches to public health interventions

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Drug users

  • Occupations of Interest

    Health Personnel

Abstract

Project Summary The COVID-19 pandemic mitigation measures are difficult for those with substance use disorder (SUD), whoare more likely to be unstably housed and do not have the economic means to comply. They may also not have access to correct communication messages about their risk. Agencies that provide services to those withSUD, such as syringe exchanges and other harm reduction organizations, have to weigh providing services totheir clients against providing a safe workspace for their employees. These organizations have had to quickly implement response plans in tandem with a fast-moving pandemic, making potential mistakes in bothmessaging to clients and response to COVID-19. This has implications for how best to plan for a futureoutbreak. The primary objective of this study is to understand how best to provide harm reduction services tothose with SUD in an infectious disease outbreak like COVID-19 by understanding how a large syringeexchange plans for and implements a plan and how clients conceptualize an outbreak, prioritize it within thecontext of their other daily risks, and determine what they expect from an agency that provides them harmreduction services. To do this, we will retrospectively investigate how COVID-19 was prioritized by clients of a Philadelphia syringe exchange and how organizational decisions about risk mitigation helped or hurt thatprioritization. Utilizing the RE-AIM Implementation Framework as a guide, we will use a mixed methodsapproach with qualitative in-depth interviews, quantitative mathematically modeled maps from commercialmarketing techniques, and a comprehensive review of planning documents, mitigation policies, and implementation plans. Specific aims are: 1. Assess perceptions of COVID-19 messaging. We will survey clients (n=100) and syringe exchange staff (n=50) and use perceptual mapping and vector modeling analysis to understand how communication of COVID-19 was processed and to inform development of more targeted and effective communication and messaging for future events.; and, 2. Analyze organizational response and COVID-19 plan implementation and develop an action plan. Using the RE-AIM Implementation Framework,we will perform an analysis of framework domains by conducting an implementation assessment. We will use survey data, conduct in-depth interviews with syringe exchange leadership (n=6), staff (n=15) and clients(n=15) and do a comprehensive review of planning documents and implementation of mitigation policies tounderstand how the planning and implementation was carried out. This analysis will then inform strategies forfuture responses through the development of an action plan. These methods aim to elucidate perceptions of COVID-19 messaging and assess decision making around the response from all stakeholders to better understand how to provide targeted communication and evidence-informed responses to potential new waves of this outbreak or similar future outbreaks.